Amster Labs IPO Details

SME NSE

Amster Labs IPO Summary

Amster Labs IPO DRHP (Draft Red Herring Prospectus) has been Filed with Exchange.

Pre-issue shareholding stands at 1,48,37,603, which will increase to 2,01,46,403 post-issue.

Amster Labs IPO carries a ₹0 (0%) GMP, reflecting investor sentiment.

The Lead Managers for Amster Labs IPO are crucial for the offering's success. They are responsible for a wide range of tasks, including preparing the company for the public market, managing the regulatory filings, and marketing the IPO to potential investors. The lead manager for this offering is Fast Track Finsec Pvt Ltd. To assess their past performance and success in previous IPOs, you can view the Lead Manager Performance Summary report.

For detailed information, Refer to the Amster Labs Limited DRHP.

Amster Labs IPO Details

Open Date

Close Date

Listing Date

Issue Price

₹0 - ₹0

Face Value

₹10 per share

Lot Size

0 Shares

GMP

₹0

Issue Type

IPO

Listing On

NSE

Type

Book Built Issue

Pre-issue Shareholding

1,48,37,603 shares

Post-issue Shareholding

2,01,46,403 shares

Total Issue Size

Fresh Issue

Offer for Sale

DRHP Status

Filed with Exchange

Amster Labs IPO Lot Size

Application	Lots	Shares	Amount
To be announced

Amster Labs IPO Reservation

Promoter Holding

Pre Issue:

72.79%

Post Issue:

53.6%

Promoter Names:

Mr. Uttamjit Singh Sabharwal, Ms. Bharminder Kaur Sabharwal, Mr. Rajinder Raheja, Mr. Satyan Anand, Mr. Amit Gupta, Mr. Rishabh Raheja

Documents

DRHP

Amster Labs IPO DRHP

Amster Labs IPO Valuations

ROE65.05%

ROCE27.62%

DEBT/EQUITY0.24

PAT MARGIN7.81%

Amster Labs Financial Information

Period Ended	31 Mar 2024	31 Mar 2023	31 Mar 2022
Assets	110.63	75.38	69.05
Total Income	35.5	105.29	96.97
Profit After Tax	5.8	2.43	1.23
Net Worth	16.55	11.78	9.44
Reserves and Surplus	9.12	8.36	6.03
Total Borrowing	39.99	28.88	24.89
Amount in ₹ Crore

About Amster Labs IPO

Incorporated in September 2014, Amster Labs Limited manufactures and distributes pharmaceutical products.

The company offers a diverse range of pharmaceutical products, including ethical drugs, generic medications, and OTC solutions.

The company's portfolio includes Softgel Capsules, Herbal Soft Gelatin Capsules, Carotenoids, and Calcitriol Soft Gelatin Capsules.

They specialize in General & Beta Lactam Tablets, syrups, ointments, and powder injections for treatments such as anti-diabetic therapies, analgesics, antibiotics, and supplements.

The company's manufacturing unit is situated in Baddi, Himachal Pradesh, covering an area of 75000 square feet.

The company has ISO 9001:2015 and ISO 10002:2018 certifications to ensure product quality.

As of March 31, 2024, there are 64 employees, all on payroll and none on contract.

Competitive Strength:

Experienced Promoters and Senior Management with extensive domain knowledge.
Quality assurance and control.
Investment in latest technology and maintain our edge in the market.
Strong sales, marketing, and distribution capabilities.
Large and rapidly growing R&D capabilities across our product portfolio.
Strategic presence across the pharmaceutical value chain.

Strength Of Amster Labs IPO

To be announced

Risk Of Amster Labs IPO

To be announced

Objectives Amster Labs IPO

1. Setting up of new manufacturing unit and unification of existing divisions

2. Working Capital Requirement

3. General Corporate Purposes

Company Contact Details

Amster Labs Ltd.
SCO 166-167, Level 1,
Sector 9C, Madhya Marg,
Sector 9
Chandigarh, Chandigarh, 160009
Phone: 0172-4183370
Email: cs@amsterlabs.in
Website: http://www.amster.in/

Registrar Contact Details

Name:

Skyline Financial Services Pvt Ltd

Phone:

+91-22-28511022

Email:

ipo@skylinerta.com

Website:

https://www.skylinerta.com/ipo.php

Lead Mangers

Market Maker

To be announced

Amster Labs FAQs

The Amster Labs IPO is a SME public issue comprising 0 equity shares with a face value of ₹10 each, aggregating to a total issue size of . The issue price has been fixed at ₹0 per equity share, and the minimum application size is 0 shares.

The IPO opens for subscription on TBA, and closes on TBA.

Skyline Financial Services Pvt Ltd has been appointed as the registrar to the issue. The equity shares are proposed to be listed on the NSE

The Amster Labs IPO opens on TBA.

Amster Labs IPO lot size is 0, and the minimum amount required for application is ₹0.

You may apply for the Amster Labs IPO online by using either the UPI or ASBA payment method. The ASBA facility is available through the net banking platform of your respective bank. The UPI-based IPO application option is typically provided by brokers that do not offer banking services. For detailed guidance on the online IPO application process, please refer to the procedures outlined by Zerodha, Groww, Upstox, 5Paisa, Paytm Money, Fyers, Alice Blue, Nuvama, HDFC Bank, ICICI Direct, Kotak Securities, Axis Direct, and SBI Bank.

The Basis of Allotment for the Amster Labs IPO is scheduled to be finalized on TBA. Subsequently, the shares allotted will be credited to investors’ demat accounts by TBA. Investors are advised to regularly check the Amster Labs IPO allotment status for updates.

The listing date for the Amster Labs IPO has not yet been officially announced. However, the tentative listing date is scheduled for TBA.

Amster Labs IPO Grey Market Premium (GMP) refers to the unofficial price at which the company’s IPO shares are traded in the grey market prior to their listing on the stock exchange. The GMP serves as an indicator of investor demand, expected listing gains, and the overall market sentiment toward the IPO.

As of now, the current GMP stands at TBA.